1. Resources and Training
  2. Ophthalmology
  3. Product resources and training
  4. ▼BEOVU® (brolucizumab) resources
  5. Resources for HCPs to provide to patients

Prescribing information

 

Resources for HCPs to provide to patients

Useful tools and resources for HCPs to share with patients who have been prescribed ▼Beovu® (brolucizumab) for the treatment of wet AMD.

__________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________

 

“”

BEOVU AND YOU: PATIENT BOOKLET

This booklet contains information for patients about:

  • What is Beovu and why they have been prescribed it
  • What to expect from treatment with Beovu, including possible side effects
  • Their appointments and how to monitor their vision (including Amsler grid)
  • Where to find further information and support.

Download

 

 

AMD, age-related macular degeneration; HCP, healthcare professional.

BEO20-C039n September 2020.
Ophthalmology
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]